Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis Presented in part at the 17th Annual North American Cystic Fibrosis Conference.
dc.contributor.author | Nazer, Dena | en_US |
dc.contributor.author | Abdulhamid, Ibrahim | en_US |
dc.contributor.author | Thomas, Ronald | en_US |
dc.contributor.author | Pendleton, Sara | en_US |
dc.date.accessioned | 2007-09-18T19:23:11Z | |
dc.date.available | 2007-09-18T19:23:11Z | |
dc.date.issued | 2006-08 | en_US |
dc.identifier.citation | Nazer, Dena; Abdulhamid, Ibrahim; Thomas, Ronald; Pendleton, Sara (2006). "Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis Presented in part at the 17th Annual North American Cystic Fibrosis Conference. ." Pediatric Pulmonology 41(8): 744-749. <http://hdl.handle.net/2027.42/55805> | en_US |
dc.identifier.issn | 8755-6863 | en_US |
dc.identifier.issn | 1099-0496 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/55805 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16779852&dopt=citation | en_US |
dc.description.abstract | To compare the effectiveness of home versus hospital intravenous (IV) antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis (CF). A retrospective chart review was performed of 143 encounters for pulmonary exacerbations in 50 patients with CF. All encounters were categorized into two groups based on location of completion of antibiotic therapy: hospital group completed treatment in hospital (n = 64), home group completed treatment at home (n = 79). Percent change was calculated for forced vital capacity (FVC), forced expiratory volume in 1 sec (FEV1), forced expiratory flow rate between 25 percent and 75 percent of vital capacity (FEF 25–75% ), maximum forced expiratory flow (FEF max ), oxygen saturation (O2 SAT), and weight. Means of percent change (PC) from the beginning to the end of IV antibiotic treatment in outcome variables were compared. Total duration of treatment was compared between the two groups. The two groups had no significant differences at baseline in all outcome variables. Treatment of exacerbations in both groups resulted in significant improvement of lung function, O2 SATS, and weight ( P ≤ 0.001). The percent change in FEV1 was greater in hospital group versus home group ( P = 0.04). The duration of treatment was significantly shorter in the hospital group ( P = 0.001). Home and hospital IV antibiotic therapy resulted in significant improvement in lung function and weight. Hospital therapy, however, resulted in significantly greater improvement in FEV-1 and required less duration of treatment as compared to home treatment in children with CF. Pediatr Pulmonol. 2006; 41: 744–749. © 2006 Wiley-Liss, Inc. | en_US |
dc.format.extent | 71962 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Miscellaneous Medical | en_US |
dc.title | Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis Presented in part at the 17th Annual North American Cystic Fibrosis Conference. | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pediatrics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationother | Department of Pediatric Education, Children's Hospital of Michigan, Wayne State University, Detroit, Michigan | en_US |
dc.contributor.affiliationother | The Carman and Ann Adams Department of Pediatrics, Division of Pulmonary Medicine, Children's Hospital of Michigan, Wayne State University, Detroit, Michigan ; Children's Hospital of Michigan, 3901 Beaubien Boulevard, Detroit, MI. 48201. | en_US |
dc.contributor.affiliationother | Children's Research Center of Michigan, Children's Hospital of Michigan, Wayne State University, Detroit, Michigan | en_US |
dc.contributor.affiliationother | The Carman and Ann Adams Department of Pediatrics, Children's Hospital of Michigan, Wayne State University, Detroit, Michigan | en_US |
dc.identifier.pmid | 16779852 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/55805/1/20433_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1002/ppul.20433 | en_US |
dc.identifier.source | Pediatric Pulmonology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.